nan 190 has been researched along with citalopram in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (71.43) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carrupt, PA; Gaillard, P; Schambel, P; Testa, B | 1 |
Dawson, IM; Hodgkiss, JP; Kelly, JS | 1 |
Bjorvatn, B; Bjørkum, AA; Neckelmann, D; Ursin, R | 1 |
Ikeda, Y; Itoyama, Y; Izumi, J; Kato, H; Kogure, K; Nakata, N; Suda, H; Tanaka, Y | 1 |
Hashimoto, S; Inoue, T; Koyama, T | 1 |
Anderson, ML; Behrens, CJ; Heinemann, U; Hollnagel, JO; Sherkheli, MA; ul Haq, R; Worschech, F | 1 |
Aguilar-Magaña, D; Atzori, M; Canto-Bustos, M; Cervantes-Ramírez, V; Góngora-Alfaro, JL; Pérez-Padilla, EA; Pineda, JC; Salgado, H | 1 |
7 other study(ies) available for nan 190 and citalopram
Article | Year |
---|---|
Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models.
Topics: Indoles; Ligands; Models, Molecular; Molecular Conformation; Molecular Structure; Piperazines; Propanolamines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Structure-Activity Relationship; Tetrahydronaphthalenes | 1996 |
An intracellular study of the action of NAN-190 on neurons in the dorsal raphe nucleus of the rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Citalopram; Dose-Response Relationship, Drug; Evoked Potentials; In Vitro Techniques; Male; Membrane Potentials; Neurons; Piperazines; Raphe Nuclei; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Tetrahydronaphthalenes | 1992 |
Sleep and EEG power spectrum effects of the 5-HT1A antagonist NAN-190 alone and in combination with citalopram.
Topics: Animals; Behavior, Animal; Citalopram; Drug Interactions; Electroencephalography; Male; Piperazines; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sleep; Sleep Stages; Sleep, REM; Synapses; Wakefulness | 1996 |
Role of hippocampal serotonergic neurons in ischemic neuronal death.
Topics: 5,7-Dihydroxytryptamine; Animals; Brain Ischemia; Buspirone; Carotid Arteries; Cell Death; Citalopram; Gerbillinae; Hippocampus; Injections; Male; Neurons; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists | 1997 |
Effects of the co-administration of 5-HT1A receptor antagonists with an SSRI in conditioned fear stress-induced freezing behavior.
Topics: Animals; Behavior, Animal; Citalopram; Conditioning, Psychological; Drug Synergism; Fear; Male; Piperazines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Stress, Physiological | 1997 |
Serotonin dependent masking of hippocampal sharp wave ripples.
Topics: Animals; Biophysics; Citalopram; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Nerve Net; Piperazines; Presynaptic Terminals; Rats; Rats, Wistar; Serotonin; Serotonin Agents | 2016 |
Citalopram reduces glutamatergic synaptic transmission in the auditory cortex via activation of 5-HT1A receptors.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Auditory Cortex; Citalopram; Excitatory Postsynaptic Potentials; Glutamic Acid; Male; Piperazines; Pyramidal Cells; Rats; Rats, Wistar; Serotonin Antagonists; Serotonin Receptor Agonists; Synaptic Transmission | 2019 |